
SymBiosis
North America, Arkansas, United States, Bentonville
Description
SymBiosis is a venture capital firm.
Investor Profile
SymBiosis has backed more than 12 startups, with 6 new investments in the last 12 months alone. The firm has led 4 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series E rounds (top funding stages).
- Majority of deals are located in United States, Australia, Canada.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 2 rounds in the past year.
Stage Focus
- Series C (42%)
- Series B (25%)
- Series E (17%)
- Series Unknown (17%)
Country Focus
- United States (75%)
- Australia (8%)
- Canada (8%)
- France (8%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Clinical Trials
- Oncology
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does SymBiosis frequently co-invest with?
Which angels does SymBiosis often collaborate with?
What are some of recent deals done by SymBiosis?
Find More Investors Like SymBiosis
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









